- Report
- October 2024
- 182 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- July 2024
- 150 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- August 2024
- 134 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- February 2024
- 112 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- July 2023
- 91 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- July 2023
- 90 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- October 2023
- 146 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- January 2025
- 132 Pages
Global
From €900EUR$950USD£752GBP
The Endoscopic Vessel Harvesting System (EVHS) market is a subset of the larger endoscopy market. EVHS is a minimally invasive procedure used to harvest vessels for coronary artery bypass grafting (CABG). It is a safe and effective alternative to traditional open-heart surgery, and is becoming increasingly popular due to its shorter recovery time and reduced risk of complications. EVHS systems typically include a console, a monitor, and a handpiece. The console is used to control the handpiece, which is used to cut and remove the vessels. The monitor displays the images of the vessels and allows the surgeon to accurately identify and harvest them.
Some of the major companies in the EVHS market include Medtronic, Stryker, and Terumo. Other companies include Cardiac Dimensions, CardioVascular Dynamics, and CardioMEMS. Show Less Read more